JILL COVERT: Open Payments
NPI 1295487775 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,237 in 102 payments from 18 companies in 2025. Trend: 2023 $568 · 2024 $2,855 · 2025 $2,237
Food & beverage: $2,138Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $686 |
| Madrigal Pharmaceuticals | 12 | $308 |
| Janssen Biotech, Inc. | 10 | $267 |
| Ardelyx, Inc. | 8 | $151 |
| GENZYME CORPORATION | 1 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| VIVUS LLC | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| QOL Medical, LLC | 3 | $62 |
| Lilly USA, LLC | 3 | $56 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, IBSRELA, DUPIXENT, SKYRIZI, LINZESS, XIFAXAN.
Industry payments across OH — which companies pay providers there.
